Literature DB >> 9065297

Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC.

M A Rodríguez-Bigas1, H F Vasen, J Pekka-Mecklin, T Myrhøj, P Rozen, L Bertario, H J Järvinen, J R Jass, K Kunitomo, T Nomizu, D L Driscoll.   

Abstract

OBJECTIVE: The authors analyzed the incidence of rectal cancer in patients with hereditary nonpolyposis colorectal cancer (HNPCC) after an abdominal colectomy. SUMMARY BACKGROUND DATA: The treatment of choice for a newly diagnosed patient with HNPCC with colon cancer is an abdominal colectomy. The incidence of rectal cancer after abdominal colectomy in HNPCC is not known.
MATERIALS AND METHODS: A questionnaire was mailed to all International Collaborative Group on HNPCC members to identify patients in whom rectal cancer developed after total, subtotal or completion colectomy. Statistics were performed using the log-rank test, Kaplan-Meier method, and Cox's proportional hazards model.
RESULTS: Rectal cancer developed in 8 (11%) of 71 patients a median of 158 months (range, 38-282 months) from their primary procedure. Of these eight patients, adenomas in the rectal mucosa developed in five at risk either before (4) or synchronous (1) with the diagnosis of rectal cancer. At the time of diagnosis of rectal cancer, six of eight patients were being observed. Age at first procedure and whether the patient was under surveillance were the only significant variables (p < 0.05) in the multivariate analysis in terms of rectal cancer risk. The risk of developing rectal cancer was estimated to be 3% every 3 years after abdominal colectomy for the first 12 years.
CONCLUSIONS: The risk of rectal cancer in patients with HNPCC after an abdominal colectomy is approximately 12% at 12 years. Age at first surgical procedure and surveillance correlated with rectal cancer risk. Aggressive endoscopic surveillance of the rectum should be performed after abdominal colectomy.

Entities:  

Mesh:

Year:  1997        PMID: 9065297      PMCID: PMC1190649          DOI: 10.1097/00000658-199702000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta.

Authors:  P J Westlake; H E Bryant; S A Huchcroft; L R Sutherland
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

2.  Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; J P Mecklin; P Sistonen
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

Review 3.  The clinical and genetic manifestations of hereditary nonpolyposis colorectal carcinoma.

Authors:  J C D'Emilia; M A Rodriguez-Bigas; N J Petrelli
Journal:  Am J Surg       Date:  1995-03       Impact factor: 2.565

4.  A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden.

Authors:  L A Aaltonen; R Sankila; J P Mecklin; H Järvinen; E Pukkala; P Peltomäki; A de la Chapelle
Journal:  Cancer Detect Prev       Date:  1994

5.  Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group.

Authors:  J J De Cosse; S Bülow; K Neale; H Järvinen; T Alm; R Hultcrantz; F Moesgaard; C Costello
Journal:  Br J Surg       Date:  1992-12       Impact factor: 6.939

6.  Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.

Authors:  M Aarnio; J P Mecklin; L A Aaltonen; M Nyström-Lahti; H J Järvinen
Journal:  Int J Cancer       Date:  1995-12-20       Impact factor: 7.396

Review 7.  Prevalence of hereditary nonpolyposis colorectal carcinoma (HNPCC).

Authors:  M Ponz de Leon
Journal:  Ann Med       Date:  1994-06       Impact factor: 4.709

8.  Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system.

Authors:  N C Davis; E B Evans; J R Cohen; D E Theile
Journal:  Dis Colon Rectum       Date:  1984-11       Impact factor: 4.585

9.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Hereditary non-polyposis colorectal cancer--morphologies, genes and mutations.

Authors:  J R Jass; S M Stewart; J Stewart; M R Lane
Journal:  Mutat Res       Date:  1994-10-01       Impact factor: 2.433

View more
  23 in total

1.  History of the International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer.

Authors:  Henry T Lynch; Giuseppe Cristofaro; Paul Rozen; Hans Vasen; Patrick Lynch; Jukka-Pekka Mecklin; Jim St John
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 2.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

Review 3.  Prophylactic surgery in Lynch syndrome.

Authors:  V Celentano; G Luglio; G Antonelli; R Tarquini; L Bucci
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

4.  Histopathological identification of colon cancer with microsatellite instability.

Authors:  J Alexander; T Watanabe; T T Wu; A Rashid; S Li; S R Hamilton
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 5.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

6.  Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.

Authors:  J Young; L A Simms; K G Biden; C Wynter; V Whitehall; R Karamatic; J George; J Goldblatt; I Walpole; S A Robin; M M Borten; R Stitz; J Searle; D McKeone; L Fraser; D R Purdie; K Podger; R Price; R Buttenshaw; M D Walsh; M Barker; B A Leggett; J R Jass
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

7.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

Review 8.  [Hereditary colorectal cancer].

Authors:  G Möslein
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

9.  The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study.

Authors:  W Müller; L J Burgart; R Krause-Paulus; S N Thibodeau; M Almeida; T B Edmonston; C R Boland; C Sutter; J R Jass; A Lindblom; J Lubinski; K MacDermot; D S Sanders; H Morreau; A Müller; C Oliani; T Orntoft; M Ponz De Leon; C Rosty; M Rodriguez-Bigas; J Rüschoff; A Ruszkiewicz; J Sabourin; R Salovaara; G Möslein
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

10.  Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect.

Authors:  W H de Vos tot Nederveen Cappel; E Buskens; P van Duijvendijk; A Cats; F H Menko; G Griffioen; J F Slors; F M Nagengast; J H Kleibeuker; H F A Vasen
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.